Florida HGH Treatment Save 60%

Anti-Aging and Wellness Medical has been working on reducing the extraordinary price markup on prescription drugs like HGH for US citizens through a distinct combination of medical tourism and doctors who are US citizens serving overseas or are dual licensed in Florida and in our international treatment destinations. This enables us to prescribe HGH which is FDA approved in the US from our overseas locations at a 60% discount for patients who qualify. 

Patients must perform proper blood testing, medical history questionnaire, and clinical exams prior to being treated. However, once treatment is prescribed, follow up consultation can be performed via telemedicine for up to 1-2 years depending on the treatment prescribed. 

Patients trust us because we have assembled a highly qualified team of board-certified physicians in the US and abroad with extensive experience in bioidentical hormone replacement therapy, weight-loss, urology, stem cells, platelet-rich plasma therapy, and more. 

For example, if you were to elect services at our Costa Rica clinic you would be secure in knowing that Dr. Ugalde is not only board-certified in Anti-Aging and Regenerative Medicine by the American Acadamy of Anti-Aging Medicine, but he also holds dual Costa Rican and US citizenship. In fact, he did his premedical training and his anti-aging boards in the United States. Dr. Ugalde has treated countless patients from Florida seeking a more economical cost to US prescription drug prices like HGH. Medical tourism is booming internationally has the US medical system is no longer optimized to serve the middle class. Savvy patients with an interest in wellness and longevity turn to us in Costa Rica, Mexico, and Panama. 

For those who are still skeptical, we also have access to board-certified physician Dr. Henderson. Dr. Henderson is licensed in Florida as well as Costa Rica. In fact, he is one of the only US physicians who is licensed in the US and Costa Rica. So, whether you speak English or Spanish, one point that will hit home with our medical care is competence and value. It is unmatched in the industry. 

The success of our multinational structure is second to none since we are really the first to create such an innovative approach in medicine. It combines medical tourism with US doctors and treatment centers abroad with the brand consistency of a global hotel chain. With our program, we can reduce treatment costs by 60% or more for HGH therapy. When patients follow our system, they receive excellent US-style standard-of-care along with access to the same medications like HGH for much less. The great benefit for patients is a choice in how they manage their aging process. Patients need not be a high-tech billionaire or Hollywood movie star to have access to these therapies. 

Big Problem: Americans are Desperate for Better Prescription Drug Prices

As many are aware, this isn’t just an HGH cost problem. Many medications like insulin and others are much higher in the USA than other countries like Canada and Mexico. A recent report shows how many diabetics are traveling to Canada for their insulin treatment because “Big Pharma” has inflated the prices for it in the USA. Ironically, some of the largest leading insulin producers are also the same leading HGH manufacturers. Anyone who experiences this sort of price gap for the same medications knows it’s unfair and must change. Meanwhile, we do what we can to keep our rates at a level which doesn’t sacrifice quality, while delivering exceptional price value for patients.

Click on the report link here: <Read more about the 2019 CBS news report on this with this link>.

Can the US Government Reduce Prescription Prices?

Lawmakers on both sides of the political spectrum have aggressively pushed to rectify price imbalances. Yet little if anything has been done to bring down the ridiculously high cost of HGH and other prescription drug therapies in the USA. Listen to both President Trump and former Senator Al Franken in the videos below addressing these concerns. Sen. Franken drills “Big Pharma” executives in Senate hearings while President Trump rails against Big Pharma, corporate lobbyist, and lack of progress on this issue from past administrations. We remain optimistic that as public awareness grows, sufficient pressure will get applied to lawmakers, regulatory bodies, and pharmaceutical companies so these price disparities are resolved equitably.